| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 74,512 |
| Provision for credit losses | 50,308 |
| Amortization of intangible assets | 12,182 |
| Amortization of mortgage servicing rights | 486 |
| Depreciation and amortization of premises and equipment | 9,505 |
| Net amortization (accretion) on portfolio loans | 12,046 |
| Net amortization (accretion) of premium (discount) on investment securities | -1,405 |
| Net amortization (accretion) of premium (discount) on time deposits | 1,715 |
| Net amortization (accretion) of premium (discount) on fhlb advances and other borrowings | 1,470 |
| Impairment of oreo and other repossessed assets | 270 |
| Impairment of fixed assets held for sale | 188 |
| Impairment of mortgage servicing rights | 35 |
| Impairment of leases | 28 |
| Unrealized (gains) losses recognized on equity securities, net | 5,490 |
| (gain) loss on sales of debt securities, net | -15,549 |
| (gain) loss on sales of mortgage servicing rights | 0 |
| (gain) loss on sales of loans, net | 1,140 |
| (gain) loss on sales of oreo and other repossessed assets | -96 |
| (gain) loss on sales of premises and equipment | -27 |
| (gain) loss on life insurance proceeds | 357 |
| (increase) decrease in cash surrender value of bank owned life insurance | 4,457 |
| Provision for deferred income taxes | -3,132 |
| Stock-based compensation | 13,125 |
| Proceeds from the sale of mortgage servicing rights | 0 |
| Mortgage loans originated for sale | 77,210 |
| Proceeds from sales of mortgage loans | 73,098 |
| (increase) decrease in other assets | 1,337 |
| Increase (decrease) in other liabilities | -31,284 |
| Net cash provided by (used in) operating activities | 120,380 |
| Purchases of equity securities | 919 |
| Purchases of debt securities available for sale | 385,411 |
| Proceeds from sales of equity securities | 6,444 |
| Proceeds from sales of debt securities available for sale | 529,760 |
| Proceeds from paydowns and maturities of debt securities held to maturity | 43,409 |
| Proceeds from paydowns and maturities of debt securities available for sale | 354,041 |
| Purchases of restricted bank stock | 35,278 |
| Proceeds from the redemption of restricted bank stock | 11,905 |
| Net (increase) decrease in loans | -161,275 |
| Net cash received in (paid for) acquisitions (see note 2) | -385,804 |
| Cash paid for premiums on bank-owned life insurance | 46 |
| Proceeds from life insurance | 4,334 |
| Purchases of premises and equipment | 13,179 |
| Proceeds from disposition of premises and equipment | 710 |
| Capitalized expenditures on foreclosed real estate | 316 |
| Proceeds from sales of oreo and other repossessed assets, including cash payments collected | 16,576 |
| Net cash provided by (used in) investing activities | 1,079,109 |
| Net increase (decrease) in deposits | -1,482,312 |
| Net increase (decrease) in federal funds purchased and securities sold under agreements to repurchase | -8,458 |
| Repayment of short-term borrowings | -11,158 |
| Proceeds from other borrowings, net of debt issuance costs | 16,667 |
| Repayment of other borrowings | 125,129 |
| Cash dividends paid | 64,259 |
| Purchase of treasury stock | 40,038 |
| Cash paid for withholding taxes on stock-based payments | 4,549 |
| Cash paid for the exercise of stock options, warrants, and ssars | -452 |
| Issuance of treasury stock for the espp | 1,487 |
| Issuance of preferred stock, net of stock issuance costs | 207,447 |
| Common stock issuance costs | 920 |
| Net cash provided by (used in) financing activities | -1,511,674 |
| Net increase (decrease) in cash and cash equivalents | -312,185 |
| Cash and cash equivalents at beginning of period | 697,659 |
| Cash and cash equivalents at end of period | 385,474 |
FIRST BUSEY CORP NV (BUSEP)
FIRST BUSEY CORP NV (BUSEP)